コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 py were treated (0 to 3 for angiosarcoma and malignant peripheral-nerve sheath tumor).
2 rative disorder, intestinal hyperplasia, and malignant peripheral nerve sheath tumor.
3 nderstanding tibial dysplasia, scoliosis and malignant peripheral nerve sheath tumors.
4 esurgical differentiation between benign and malignant peripheral nerve sheath tumors.
5 ge, 28% of tp53(M214K) mutant fish developed malignant peripheral nerve sheath tumors.
6 also develop peripheral ganglion-associated malignant peripheral nerve sheath tumors.
9 pilocytic optic pathway gliomas, as well as malignant peripheral nerve sheath tumors and glioblastom
10 ermal and plexiform neurofibromas as well as malignant peripheral nerve sheath tumors and other malig
11 iosarcomas, malignant fibrous histiocytomas, malignant peripheral-nerve sheath tumors, and Ewing's sa
12 pleomorphic sarcomas, myxofibrosarcomas, and malignant peripheral nerve sheath tumors are characteriz
13 sis and multiple isolated neurofibromas, and malignant peripheral nerve sheath tumors are covered in
14 iomas, malignant gliomas, neurofibromas, and malignant peripheral nerve sheath tumors, as well as beh
15 egulation through RAS/MAPK/AP-1 signaling in malignant peripheral nerve sheath tumor (MPNST) cell lin
16 immunohistochemistry revealed that each of 3 malignant peripheral nerve sheath tumor (MPNST) cell lin
17 chemical library screen using NF1-deficient malignant peripheral nerve sheath tumor (MPNST) cells.
20 y of these viruses against neuroblastoma and malignant peripheral nerve sheath tumor (MPNST) xenograf
23 evelopment of a variety of tumors, including malignant peripheral nerve sheath tumors (MPNST) and ben
26 ct characterizes Schwann cells in benign and malignant peripheral nerve sheath tumors (MPNST) from ne
27 tamoxifen and OHT exert cytotoxic effects in malignant peripheral nerve sheath tumors (MPNST) where e
28 t a related role has not been established in malignant peripheral nerve sheath tumors (MPNST) where N
29 rationalize clinical evaluation of HDACis in malignant peripheral nerve sheath tumors (MPNST), a clas
30 debilitating growths that can transform into malignant peripheral nerve sheath tumors (MPNST), a main
34 the potential for malignant transformation (malignant peripheral nerve sheath tumor; MPNST), its neo
36 rding the status of cell cycle regulators in malignant peripheral nerve sheath tumors (MPNSTs) and ne
37 ncy of INK4A gene alterations in a series of malignant peripheral nerve sheath tumors (MPNSTs) and ne
47 DSS was significantly worse in primary RAS malignant peripheral nerve sheath tumors (MPNSTs) compar
50 with morphologic imaging, in differentiating malignant peripheral nerve sheath tumors (MPNSTs) from b
51 s type 1-derived Schwann cells isolated from malignant peripheral nerve sheath tumors (MPNSTs) overex
54 cing-based comparative methylome analysis of malignant peripheral nerve sheath tumors (MPNSTs), benig
55 urofibromatosis 1 and its lethal derivative, malignant peripheral nerve sheath tumors (MPNSTs), is th
56 s infancy, this approach is being applied to malignant peripheral nerve sheath tumors (MPNSTs), rare
57 d germ line mutations in Nf1 and p53 develop malignant peripheral nerve sheath tumors (MPNSTs), which
63 have a greatly increased risk of developing malignant peripheral nerve sheath tumors (MPNSTs).These
64 s (n = 30), five osteosarcomas (n = 27), one malignant peripheral-nerve sheath tumor (n = 7), 0 rhabd
65 anglioneuroma-pheochromocytoma, and two with malignant peripheral nerve sheath tumor (PNST) that aros
66 the extremities that histologically resemble malignant peripheral nerve sheath tumors, rare neoplasms
67 nt progression of plexiform neurofibromas to malignant peripheral nerve sheath tumors requires additi
68 tudying the molecular pathogenic pathways of malignant peripheral nerve sheath tumors, these mutant z
69 one dedifferentiated chondrosarcoma, and one malignant peripheral nerve sheath tumor) were analyzed.
70 mors such as neurofibromas, schwannomas, and malignant peripheral nerve sheath tumors, were presented
71 ds and an absence of TGF-beta receptor II in malignant peripheral nerve sheath tumors, which correspo
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。